Skip to main content
Top
Published in: World Journal of Surgery 4/2004

01-04-2004 | Original Scientific Reports

Palliation of Metastatic Gastric Cancer: Impact of Preoperative Symptoms and the Type of Operation on Survival and Quality of Life

Authors: Volker Kahlke, M.D., Beate Bestmann, M.A., Andreas Schmid, M.D., Julius Marek Doniec, M.D., Thomas Küchler, Ph.D., Bernd Kremer, M.D.

Published in: World Journal of Surgery | Issue 4/2004

Login to get access

Abstract

Patients with advanced, incurable gastric cancer may present with mild symptoms or require immediate therapeutic intervention. The influence of the intensity of preoperative symptoms on postoperative survival and quality of life (QoL) was evaluated in a palliative setting. In a historical cohort analysis of 492 patients with gastric cancer treated between 1992 and 2001, a total of 169 (34.4%) patients had incurable disease (i.e., pTxNxM1). Patients were classified as having major symptoms if they presented with upper gastrointestinal bleeding (i.e., hematemesis or bloody stools), gastric inlet or outlet obstruction (i.e., symptomatic and endoscopically proven stenosis), or perforation caused by the tumor. All other patients were defined as having minor symptoms. QoL was assessed prospectively using the EORTC questionnaire. The questionnaire was given to the patients before operation, before discharge, and 3 months after operation; and it was analyzed by the Mann-Whitney U-test. Survival, demographic data, and histopathologic characteristics were assessed and analyzed by the log-rank test and the χ2 test, respectively. Of the 169 patients, 75 (44.3%) presented with major symptoms and 94 (55.7%) with minor symptoms. The distribution of patients undergoing resection or exploration was comparable for the two groups [major: 61 (81.5%)/14 (18.5%); minor: 77 (81.9%)/17 (18.1%)]. Despite comparable demographic and histopathologic characteristics with equal hospital mortality and morbidity (14.6% vs. 8.5%/49.3% vs. 40.4%), the median survival rates in two groups were 4 and 6 months, respectively (p < 0.05). This was not influenced by the type of operation. QoL was not different in patients with major or minor symptoms before operation or 3 months thereafter. However, preoperative symptoms such as nausea/vomiting and melena were rated significantly higher in patients with major symptoms. In patients with incurable gastric cancer the preoperative intensity of symptoms has a significant impact on survival and QoL, which is not influenced by the operation. The necessity of surgery in patients with minor symptoms requires careful consideration.
Literature
1.
go back to reference Sugarbaker, PH, Yonemura, Y 2000Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cureOncology5896107CrossRefPubMed Sugarbaker, PH, Yonemura, Y 2000Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cureOncology5896107CrossRefPubMed
2.
go back to reference Monson, JR, Donohue, JH, McIlrath, DC, et al. 1991Total gastrectomy for advanced cancer: a worthwhile palliative procedureCancer6818631868PubMed Monson, JR, Donohue, JH, McIlrath, DC,  et al. 1991Total gastrectomy for advanced cancer: a worthwhile palliative procedureCancer6818631868PubMed
3.
go back to reference Meijer, S, Bakker, OJ, Hoitsma, HF 1983Palliative resection in gastric cancerJ. Surg. Oncol.237780PubMed Meijer, S, Bakker, OJ, Hoitsma, HF 1983Palliative resection in gastric cancerJ. Surg. Oncol.237780PubMed
5.
go back to reference Kuhn, R, Ridwelski, K 2000Die Therapie des fortgeschrittenen MagenkarzinomsAkt. Studienkonzepte Zentralbl. Chir.125176181 Kuhn, R, Ridwelski, K 2000Die Therapie des fortgeschrittenen MagenkarzinomsAkt. Studienkonzepte Zentralbl. Chir.125176181
6.
go back to reference Ouchi, K, Sugawara, T, Ono, H, et al. 1998Therapeutic significance of palliative operations for gastric cancer for survival and quality of lifeJ. Surg. Oncol.694144CrossRefPubMed Ouchi, K, Sugawara, T, Ono, H,  et al. 1998Therapeutic significance of palliative operations for gastric cancer for survival and quality of lifeJ. Surg. Oncol.694144CrossRefPubMed
7.
go back to reference Kikuchi, S, Arai, Y, Kobayashi, N, et al. 2000Is extended lymphadenectomy valuable in palliatively gastrectomized patients with gastric cancer and simultaneous peritoneal metastasis?Hepatogastroenterology.47563566PubMed Kikuchi, S, Arai, Y, Kobayashi, N,  et al. 2000Is extended lymphadenectomy valuable in palliatively gastrectomized patients with gastric cancer and simultaneous peritoneal metastasis?Hepatogastroenterology.47563566PubMed
8.
go back to reference Schmier, J, Elixhauser, A, Halpern, MT 1999Health-related quality of life evaluation of gastric and pancreatic cancerHepatogastroenterology.4619982004PubMed Schmier, J, Elixhauser, A, Halpern, MT 1999Health-related quality of life evaluation of gastric and pancreatic cancerHepatogastroenterology.4619982004PubMed
9.
go back to reference Thybusch-Bernhardt, A, Schmidt, C, Kuchler, T, et al. 1999Quality of life following radical surgical treatment of gastric carcinomaWorld J. Surg.23503508PubMed Thybusch-Bernhardt, A, Schmidt, C, Kuchler, T,  et al. 1999Quality of life following radical surgical treatment of gastric carcinomaWorld J. Surg.23503508PubMed
10.
go back to reference Aaronson, NK, Ahmedzai, S, Bergman, B, et al. 1993The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ. Natl. Cancer Inst.85365376CrossRefPubMed Aaronson, NK, Ahmedzai, S, Bergman, B,  et al. 1993The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ. Natl. Cancer Inst.85365376CrossRefPubMed
11.
go back to reference Fayers P, Aaronson NK, Bjordal D, et al. EORTC QLQ-C30 Scoring Manual, 2nd edition, Paris, EORTC Fayers P, Aaronson NK, Bjordal D, et al. EORTC QLQ-C30 Scoring Manual, 2nd edition, Paris, EORTC
12.
go back to reference Doglietto, GB, Pacelli, F, Caprino, P, et al. 2000Surgery: independent prognostic factor in curable and far advanced gastric cancerWorld J. Surg.24459464CrossRefPubMed Doglietto, GB, Pacelli, F, Caprino, P,  et al. 2000Surgery: independent prognostic factor in curable and far advanced gastric cancerWorld J. Surg.24459464CrossRefPubMed
13.
go back to reference Kikuchi, S, Tsutsumi, O, Kobayashi, N, et al. 1999Does gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation?Hepatogastroenterology.46584587PubMed Kikuchi, S, Tsutsumi, O, Kobayashi, N,  et al. 1999Does gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation?Hepatogastroenterology.46584587PubMed
14.
go back to reference Hanazaki, K, Sodeyama, H, Mochizuki, Y, et al. 2001Palliative gastrectomy for advanced gastric cancerHepatogastroenterology.48285289PubMed Hanazaki, K, Sodeyama, H, Mochizuki, Y,  et al. 2001Palliative gastrectomy for advanced gastric cancerHepatogastroenterology.48285289PubMed
15.
go back to reference Kaibara, N, Okamoto, T, Kimura, O, et al. 1983Possible role of lymph node dissection in the surgical treatment of gastric cancer with disseminating peritoneal metastasisJpn. J. Surg.13404408PubMed Kaibara, N, Okamoto, T, Kimura, O,  et al. 1983Possible role of lymph node dissection in the surgical treatment of gastric cancer with disseminating peritoneal metastasisJpn. J. Surg.13404408PubMed
16.
go back to reference Koga, S, Kawaguchi, H, Kishimoto, H, et al. 1980Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasisAm. J. Surg.140356359PubMed Koga, S, Kawaguchi, H, Kishimoto, H,  et al. 1980Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasisAm. J. Surg.140356359PubMed
17.
go back to reference Schmid, A, Thybusch, A, Kremer, B, et al. 2000Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patientsHepatogastroenterology.32579585 Schmid, A, Thybusch, A, Kremer, B,  et al. 2000Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patientsHepatogastroenterology.32579585
18.
go back to reference Noguchi, Y, Yamamoto, Y, Morinaga, S, et al. 2002Does pancreaticosplenectomy contribute to better survival?Hepatogastroenterology.4714361440 Noguchi, Y, Yamamoto, Y, Morinaga, S,  et al. 2002Does pancreaticosplenectomy contribute to better survival?Hepatogastroenterology.4714361440
Metadata
Title
Palliation of Metastatic Gastric Cancer: Impact of Preoperative Symptoms and the Type of Operation on Survival and Quality of Life
Authors
Volker Kahlke, M.D.
Beate Bestmann, M.A.
Andreas Schmid, M.D.
Julius Marek Doniec, M.D.
Thomas Küchler, Ph.D.
Bernd Kremer, M.D.
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 4/2004
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-003-7119-0

Other articles of this Issue 4/2004

World Journal of Surgery 4/2004 Go to the issue

The Surgeon’s Word

Vaccination